Combining 2D and 3D in silico methods for rapid selection of potential PDE5 inhibitors from multimillion compounds’ repositories: biological evaluation
- First Online:
Rapid in silico selection of target focused libraries from commercial repositories is an attractive and cost-effective approach when starting new drug discovery projects. If structures of active compounds are available rapid 2D similarity search can be performed on multimillion compounds’ databases. This in silico approach can be combined with physico-chemical parameter filtering based on the property space of the active compounds and 3D virtual screening if the structure of the target protein is available. A multi-step virtual screening procedure was developed and applied to select potential phosphodiesterase 5 (PDE5) inhibitors in real time. The combined 2D/3D in silico method resulted in the identification of 14 novel PDE5 inhibitors with <1 μMIC50 values and the hit rate in the second in silico selection and in vitro screening round exceeded the 20%.
Keywords2D similarity selection Virtual screening Phosphodiesterase 5 inhibitor 3D docking In vitro screening
Unable to display preview. Download preview PDF.
- 5.Johnson MA, Maggiora GM (1990) Concepts and applications of molecular similarity. Wiley, New YorkGoogle Scholar
- 22.Jayashankar L, Syama Sundar B (2010) Computational studies on phosphodiesterase-5 inhibitors to design novel lead compounds for the treatment of erectile dysfunction. J Pharm Sci Technol 2: 156–169Google Scholar
- 28.http://www.chemaxon.com (accessed April, 2010); InstJChem v. 5.3.1, 2010 was used for structure searching and chemical database access and management: Marvin v. 5.3.1, 2010 was used for drawing, displaying, and characterizing chemical structures and substructures: fingerprints are explained at http://www.chemaxon.com/jchem/doc/user/fingerprint.html
- 30.Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K (1998) Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3’,5’-cyclic nucleotide phosphodiesterase. Gene 216: 139–147. doi:10.1016/S0378-1119(98)00303-5 PubMedCrossRefGoogle Scholar
- 36.PharmaProjects, www.pharmaprojects.com/